NASDAQ : MLEC
Moolec Science SA — Financial statements
Healthcare · Biotechnology · Cayman Islands
Last price 1.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Moolec Science SA (MLEC) reported revenue of 7.83M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | 7.83M | 5.63M | 905.05K | |||
| Cost of Revenue | 8.47M | 5.15M | 1.05M | |||
| Gross Profit | -639.50K | 472.58K | -143.31K | |||
| Selling, General & Admin | 6.86M | 7.76M | 5.06M | 2.63M | 1.80M | 416.47K |
| Research & Development | 1.59M | 1.77M | 1.35M | 985.16K | 1.20M | 537.18K |
| Other Operating Expenses | 53.67K | -18.68K | 95.12K | 38.98K | 186.50K | 7.92K |
| Operating Expenses | 8.50M | 9.52M | 49.22M | 3.65M | 3.19M | 961.57K |
| Operating Income | -9.14M | -9.04M | -49.36M | -3.65M | -3.19M | -961.57K |
| Interest Expense | -2.18M | -1.17M | -160.03K | -2.13K | ||
| Interest & Investment Income | 1.39M | 1.39M | 693.03K | |||
| Earnings From Equity Investments | -40.85K | -780.91K | ||||
| Currency Exchange Gain (Loss) | -1.12M | -3.42M | -1.39M | -12.34K | ||
| Other Non Operating Income (Expenses) | 2.20M | 3.35M | 714.78K | -860.00K | ||
| EBT Excluding Unusual Items | -8.91M | -8.89M | -49.50M | -4.53M | -3.97M | -961.57K |
| Merger & Restructuring Charges | -3.54M | |||||
| Gain (Loss) on Sale of Investments | 281.82K | 532.86K | 1.01M | |||
| Pretax Income | -8.62M | -8.36M | -52.02M | -4.53M | -3.97M | -961.57K |
| Income Tax Expense | -342.80K | -1.05M | -234.54K | |||
| Net Income | -8.28M | -7.31M | -51.79M | -4.53M | -3.97M | -961.57K |
| Net Income to Common | -8.28M | -7.31M | -51.79M | -4.53M | -3.97M | -961.57K |
| Shares Outstanding (Basic) | 3.84M | 3.79M | 3.45M | 3.10M | 3.02M | 2.91M |
| Shares Outstanding (Diluted) | 3.84M | 3.79M | 3.45M | 3.10M | 3.02M | 2.91M |
| EPS (Basic) | -2.16 | -1.93 | -15.03 | -1.46 | -1.31 | -0.33 |
| EPS (Diluted) | -2.16 | -1.93 | -15.03 | -1.46 | -1.31 | -0.33 |
| Free Cash Flow | -6.10M | -9.49M | -7.53M | -1.89M | 1.96M | -7.80M |
| Free Cash Flow Per Share | -1.59 | -2.50 | -2.18 | -0.61 | 0.65 | -2.68 |
| Gross Margin | -8.16% | 8.40% | -15.83% | |||
| Operating Margin | -116.72% | -160.76% | -5,453.72% | |||
| Profit Margin | -105.72% | -129.99% | -5,722.22% | |||
| Free Cash Flow Margin | -77.86% | -168.65% | -831.58% | |||
| EBITDA | -8.07M | -8.16M | -49.24M | -3.65M | ||
| EBITDA Margin | -103.07% | -145.00% | ||||
| D&A For EBITDA | 1.07M | 886.55K | 120.75K | 1.70K | ||
| EBIT | -9.14M | -9.04M | -49.36M | -3.65M | -3.19M | -961.57K |
| EBIT Margin | -116.72% | -160.76% |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.93M | 5.39M | 2.53M | 1.08M | 980.53K | |
| Short-Term Investments | 306.03K | |||||
| Cash & Short-Term Investments | 1.93M | 5.39M | 2.83M | 1.08M | 980.53K | |
| Accounts Receivable | 1.93M | 471.50K | 361.10K | |||
| Other Receivables | 808.79K | 1.01M | 1.33M | 289.89K | 2.30M | |
| Receivables | 2.74M | 1.48M | 1.69M | 289.89K | 2.30M | |
| Inventory | 4.84M | 6.28M | 465.75K | |||
| Prepaid Expenses | 31.32K | 596.94K | 341.11K | 2.06K | 358.00 | |
| Total Current Assets | 9.54M | 13.75M | 5.33M | 1.08M | 1.27M | 2.30M |
| Property, Plant & Equipment | 1.63M | 1.62M | 1.19M | 8.92K | 10.62K | |
| Long-Term Investments | 2.00M | |||||
| Goodwill | 281.03K | 262.53K | 251.44K | |||
| Other Intangible Assets | 9.06M | 8.98M | 8.52M | 4.60M | 4.60M | |
| Other Long-Term Assets | 25.45K | 10.19M | 8.76M | |||
| Total Assets | 31.38M | 34.79M | 24.05M | 5.69M | 5.88M | 4.30M |
| Accounts Payable | 1.58M | 873.53K | 2.34M | 164.13K | 587.66K | 19.63K |
| Accrued Expenses | 1.77M | 2.83M | 5.36M | 1.06M | ||
| Short-Term Debt | 2.37M | 2.56M | 2.55M | |||
| Current Portion of Leases | 181.68K | 173.35K | ||||
| Current Income Taxes Payable | 74.61K | 134.21K | 23.33K | |||
| Other Current Liabilities | 486.69K | 1.58M | 2.33M | 2.86M | ||
| Total Current Liabilities | 6.46M | 8.15M | 12.60M | 4.09M | 587.66K | 19.63K |
| Long-Term Debt | 19.37M | 11.70M | 99.05K | |||
| Long-Term Leases | 166.15K | 248.53K | ||||
| Long-Term Deferred Tax Liabilities | 316.04K | 72.10K | 1.07M | |||
| Other Long-Term Liabilities | 2.27M | 7.80M | 175.31K | |||
| Total Liabilities | 28.58M | 27.97M | 13.95M | 4.09M | 587.66K | 19.63K |
| Common Stock | 401.27K | 385.64K | 375.64K | 310.00K | 638.30K | 600.00K |
| Additional Paid-In Capital | 70.15M | 69.16M | 67.00M | 7.29M | 6.96M | 4.00M |
| Retained Earnings | -70.28M | -65.94M | -58.62M | -6.83M | -2.31M | -320.52K |
| Treasury Stock | -305.00K | -305.00K | ||||
| Comprehensive Income & Other | 2.83M | 3.51M | 1.36M | 838.58K | ||
| Shareholders' Equity | 2.80M | 6.82M | 10.11M | 1.60M | 5.29M | 4.28M |
| Total Liabilities & Equity | 31.38M | 34.79M | 24.05M | 5.69M | 5.88M | 4.30M |
| Total Debt | 22.09M | 14.68M | 2.65M | |||
| Net Cash (Debt) | -20.16M | -9.29M | 188.42K | 1.08M | 980.53K | |
| Net Cash Per Share | -5.25 | -2.45 | 0.05 | 0.35 | 0.32 | |
| Filing Date Shares Outstanding | 4.00M | 3.84M | 3.76M | 3.10M | 1.74M | 2.91M |
| Total Common Shares Outstanding | 4.00M | 3.84M | 3.76M | 3.10M | 1.74M | 2.91M |
| Working Capital | 3.09M | 5.60M | -7.27M | -3.00M | 683.12K | 2.28M |
| Book Value Per Share | 0.70 | 1.77 | 2.69 | 0.52 | 3.05 | 1.47 |
| Tangible Book Value | -6.54M | -2.42M | 1.34M | -2.99M | 693.73K | 4.28M |
| Tangible Book Value Per Share | -1.63 | -0.63 | 0.36 | -0.97 | 0.40 | 1.47 |
| Machinery | 1.31M | 1.11M | 10.62K | 10.62K | ||
| Construction In Progress | 2.60K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Net Income | -8.28M | -7.31M | -51.79M | -4.53M | -3.97M | -961.57K |
| Depreciation & Amortization | 1.19M | 1.01M | 120.75K | 1.70K | ||
| Other Amortization | 3.98K | 3.98K | 1.27K | |||
| Loss (Gain) on Equity Investments | 780.91K | |||||
| Stock-Based Compensation | 866.66K | 2.05M | 43.80M | 838.58K | ||
| Other Operating Activities | -1.26M | -2.03M | -1.37M | 874.47K | ||
| Change in Accounts Receivable | -1.47M | -94.47K | -44.13K | |||
| Change in Inventory | -3.72M | -5.79M | 66.48K | |||
| Change in Accounts Payable | 6.24M | 2.50M | 1.49M | 926.71K | 1.14M | 58.90K |
| Change in Other Net Operating Assets | 740.63K | 338.90K | 221.89K | -532.00 | 4.02M | -6.90M |
| Operating Cash Flow | -5.70M | -9.33M | -7.51M | -1.89M | 1.96M | -7.80M |
| Capital Expenditures | -402.06K | -158.28K | -14.82K | |||
| Cash Acquisitions | -1.93M | |||||
| Sale (Purchase) of Intangibles | -17.90K | -164.36K | ||||
| Investment in Securities | 149.79K | 293.15K | -226.75K | |||
| Investing Cash Flow | -270.17K | 134.87K | -2.34M | |||
| Long-Term Debt Issued | 13.53M | 2.17M | ||||
| Long-Term Debt Repaid | -2.62M | -876.77K | ||||
| Net Debt Issued (Repaid) | 4.79M | 10.91M | 1.30M | |||
| Issuance of Common Stock | 2.20M | 2.17M | 10.01M | 2.00M | 7.80M | |
| Repurchase of Common Stock | -305.00K | -305.00K | ||||
| Other Financing Activities | -732.47K | -1.07M | -24.10K | |||
| Financing Cash Flow | 5.95M | 11.71M | 11.28M | 2.00M | 7.80M | |
| Foreign Exchange Rate Adjustments | 249.15K | 344.31K | 12.38K | -12.74K | ||
| Net Cash Flow | 228.43K | 2.86M | 1.45M | 101.28K | 1.96M | |
| Free Cash Flow | -6.10M | -9.49M | -7.53M | -1.89M | 1.96M | -7.80M |
| Free Cash Flow Margin | -77.86% | -168.65% | -831.58% | |||
| Free Cash Flow Per Share | -1.59 | -2.50 | -2.18 | -0.61 | 0.65 | -2.68 |
| Levered Free Cash Flow | -13.18M | -13.78M | 16.33M | 2.34M | ||
| Unlevered Free Cash Flow | -11.81M | -13.05M | 16.43M | 2.35M | ||
| Cash Interest Paid | 732.47K | 570.22K | 24.10K |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.91M | 41.32M | 144.74M | 173.53M | 169.70M | |
| Enterprise Value | 50.96M | 134.47M | ||||
| Last Close Price | 1.40 | 11.00 | 36.80 | 99.90 | 97.70 | |
| PS Ratio | 7.35 | 159.93 | ||||
| PB Ratio | 6.06 | 14.32 | 108.16 | 32.06 | ||
| P/TBV Ratio | 108.39 | 244.63 | ||||
| P/FCF Ratio | 86.54 | |||||
| P/OCF Ratio | 86.54 | |||||
| EV/Sales Ratio | 9.06 | 148.58 | ||||
| Debt / Equity Ratio | 7.90 | 2.15 | 0.26 | |||
| Asset Turnover | 0.30 | 0.19 | 0.06 | |||
| Inventory Turnover | 3.17 | 1.53 | ||||
| Quick Ratio | 0.72 | 0.84 | 0.36 | 0.27 | 2.16 | 117.11 |
| Current Ratio | 1.48 | 1.69 | 0.42 | 0.27 | 2.16 | 117.11 |
| Return on Equity (ROE) | -174.68% | -86.42% | -884.50% | -131.27% | ||
| Return on Assets (ROA) | -21.68% | -19.21% | -207.44% | -39.45% | ||
| Return on Invested Capital (ROIC) | -28.64% | -33.01% | -429.79% | -66.20% | ||
| Earnings Yield | -17.70% | -35.78% | -2.61% | -2.34% | ||
| FCF Yield | -209.42% | -22.96% | -5.20% | -1.09% | 1.16% | |
| Buyback Yield / Dilution | -1.44% | -9.88% | -11.18% | -2.51% | -3.77% |